120951-86-2

Basic information

• Product Name: Silane, [1,3-phenylenebis(oxy)]bis[(1,1-dimethylethyl)dimethyl-
• CAS NO: 120951-86-2
• Molecular Formula: C18H34O2Si2
• Molecular Weight: 338.638
• Mol File: 120951-86-2.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Silane, [1,3-phenylenebis(oxy)]bis[(1,1-dimethylethyl)dimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Silane, [1,3-phenylenebis(oxy)]bis[(1,1-dimethylethyl)dimethyl-(120951-86-2)
• EPA Substance Registry System: Silane, [1,3-phenylenebis(oxy)]bis[(1,1-dimethylethyl)dimethyl-(120951-86-2)

Safety Data

• Hazardous Substances Data: 120951-86-2(Hazardous Substances Data)

Upstream product

• 57918-73-7 3-acetoxy-cyclohex-2-enone 
• 69739-34-0 t-butyldimethylsiyl triflate 
• 103-49-1 dibenzylamine 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 108-46-3 recorcinol 
• 103-67-3 benzyl-methyl-amine 
• 109-89-7 diethylamine 
• 124-40-3 dimethyl amine 

Downstream Products

• 108-46-3 recorcinol 
• 1366234-66-3 ((5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-phenylene)bis(oxy))bis(tert-butyldimethylsilane) 
• 1352571-55-1 (+/-)-3-(4-(4-methoxybenzyloxy)-5-methylpyrimidin-2-yl)-5-(tetrahydrofuran-3-yloxy)phenol 
• 1352571-39-1 2-(3,5-bis(tert-butyldimethylsilyloxy)phenyl)-4-(4-methoxybenzyloxy)-5-methylpyrimidine 
• 1352571-40-4 5-(4-(4-methoxybenzyloxy)-5-methylpyrimidin-2-yl)benzene-1,3-diol 
• 1352571-41-5 3-(4-(4-methoxybenzyloxy)-5-methylpyrimidin-2-yl)-5-(4-(methylsulfonyl)phenoxy)phenol 
• 1352570-45-6 5-methyl-2-{3-[4-(methylsulfonyl)phenoxy]-5-(tetrahydrofuran-3-yloxy)phenyl}pyrimidin-4(3H)-one 
• 1352570-48-9 5-methyl-2-(3-(4-(methylsulfonyl)phenoxy)-5-(tetrahydro-2H-pyran-4-yloxy)phenyl)pyrimidin-4(3H)-one 
• 1352571-66-4 4-(4-methoxybenzyloxy)-5-methyl-2-(3-(4-(methylsulfonyl)phenoxy)-5-(tetrahydro-2H-pyran-4-yloxy)phenyl)pyrimidine 
• 1147862-00-7 1,5-bis((tert-butyldimethylsilyl)oxy)cyclohexa-1,4-diene 

Relevant articles and documents

NOVEL COMPOUNDS AND THERAPEUTICS USES THEREOF

The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and infectious diseases, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.

Asymmetric Synthesis and Structure Revision of Guignardone H and I: Development of a Chiral 1,3-Diketone Possessing C2 Symmetry

A novel chiral 1,3-diketone possessing C2 symmetry was synthesized and utilized in the asymmetric synthesis of guignardone H and I by employing sequential condensation-6?-electrocyclization reactions with the novel 1,3-diketone followed by ster

2-(3,5-DISUBSTITUTEDPHENYL)PYRIMIDIN-4(3H)-ONE DERIVATIVES

O N NH R3 R2 O R1 168 ABSTRACT The present invention provides a 2-(3,5-disubstitutedphenyl)pyrimidin- 4(3H)-one compound of Formula (I) 5 (I) or a pharmaceutically acceptable salt thereof wherein R 1, R2 and R3 are as defined herein. The compounds of Formula (I) have been found to act as glucokinase activators. Consequently, the compounds of Formula (I) and 10 the pharmaceutical compositions thereof are useful for the treatment of diseases, disorders, or conditions mediated by glucokinase.